D09Not billable, use a more specific code below

Carcinoma in situ of other and unspecified sites

In In situ neoplasms (D00-D09), chapter 2: Neoplasms

9 billable codes under D09: none are a CC or MCC; none map to an HCC.

Advertisements

Instructional notes

Excludes1: not coded here, use a different code

  • melanoma in situ (D03.-)

Also applies, from In situ neoplasms (D00-D09)

These notes sit on D00-D09 and apply to every code under it, including D09.

Includes: conditions that are coded here

  • Bowen's disease
  • erythroplasia
  • grade III intraepithelial neoplasia
  • Queyrat's erythroplasia

Official coding guidelines

From the ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027 (CMS and NCHS). Links open the PDF at the right page.

Rules for coding benign and malignant neoplasms: using the Neoplasm Table, sequencing primary and secondary sites, treatment encounters, complications, and current cancer versus personal history.

Read Section I.C.2 (page 32), 12 more topics

D09 MS-DRGs

As the principal diagnosis, the billable codes under D09 group to these 22 MS-DRGs (v44.0). Which one applies depends on procedures performed, secondary diagnoses (CC/MCC), and the patient's age and discharge status.

Other codes that refer to D09

Notes on these codes point to D09.

  • Z86.00 Includes: Conditions classifiable to D00-D09
  • Z86.008 Includes: Conditions classifiable to D09

About the condition

Plain-language background from MedlinePlus (National Library of Medicine), not coding guidance.

Cancer

Cancer is not just one disease but many diseases. Cancer begins in your cells, which are the building blocks of your body. Usually, your body forms new cells as needed, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor.

Read more about cancer on MedlinePlus

Code history

Valid since FY2016, when ICD-10-CM took effect on October 1, 2015. No changes since.